泰森生物HT100-A血糖监测系统;泰森生物HT100-C血糖监测系统
K号: K182047 · 2018-11-29
广告
器械摘要
常见问题
What is the Tyson Bio HT100-A Blood Glucose Monitoring System; Tyson Bio HT100-C Blood Glucose Monitoring System?
Tyson Bio HT100-A Blood Glucose Monitoring System; Tyson Bio HT100-C Blood Glucose Monitoring System is a medical device that received FDA 510(k) clearance on 2018-11-29. The listed applicant is Tyson Bioresearch, Inc.. The 510(k) number is K182047.
When did Tyson Bio HT100-A Blood Glucose Monitoring System; Tyson Bio HT100-C Blood Glucose Monitoring System receive FDA 510(k) clearance?
Tyson Bio HT100-A Blood Glucose Monitoring System; Tyson Bio HT100-C Blood Glucose Monitoring System received FDA 510(k) clearance on 2018-11-29, under 510(k) number K182047.
Who is the listed applicant for Tyson Bio HT100-A Blood Glucose Monitoring System; Tyson Bio HT100-C Blood Glucose Monitoring System?
The FDA 510(k) record lists Tyson Bioresearch, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Tyson Bio HT100-A Blood Glucose Monitoring System; Tyson Bio HT100-C Blood Glucose Monitoring System?
The FDA product code for Tyson Bio HT100-A Blood Glucose Monitoring System; Tyson Bio HT100-C Blood Glucose Monitoring System is NBW. This falls under the OB/GYN category.
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
列明Tyson Bioresearch, Inc.为申报人的其他记录
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
相关器械(代码:NBW)
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。
广告